These findings complement our previous report regarding the capacity of LAV-BPIFB4 gene therapy to blunt the progression of the disease in a R6/2 HD mouse model, providing new stimulant molecular mechanisms beside the neuroprotective effects exerted by the longevity variant of BPIFB4 [22]. Here, BPIFB4 is linked to ring chromosome 6.